Quetiapine (Seroquel XR) for the Treatment of Fibromyalgia: a Clinical and Mechanistic Pilot Study.

Trial Profile

Quetiapine (Seroquel XR) for the Treatment of Fibromyalgia: a Clinical and Mechanistic Pilot Study.

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Nov 2015

At a glance

  • Drugs Quetiapine (Primary)
  • Indications Fibromyalgia
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 Aug 2012 Primary endpoint 'Fibromyalgia-Impact-Questionnaire' has not been met.
    • 24 Aug 2012 Results published in the Journal of Clinical Psychopharmacology.
    • 04 Oct 2011 Actual end date (October 2011) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top